Questions in relation to Breast Cancer Treatment
Dear Shropshire Community Health NHS Trust,
I would like to please request the following information with regards to Breast Cancer Treatment.
The purpose of these questions is to understand the variability of treatment within your trust and in context to the rest of the country.
Q1. In the past 3 months (or the latest 3 months data you have available), how many Metastatic/advanced Breast cancer patients were treated with:
• Abemaciclib (Verzenios) + aromatase inhibitor *
• Abemaciclib (Verzenios) + Fulvestrant (Faslodex)
• Alpelisib (Piqray) + Fulvestrant (Faslodex)
• Atezolizumab (Tecentriq)**
• Bevacizumab (Avastin)
• Eribulin (Halaven)
• Everolimus (Afinitor) + Exemestane
• Fulvestrant (Faslodex) as a single agent
• Gemcitabine + paclitaxel
• Herceptin (Trastuzumab) + paclitaxel
• Herceptin (Trastuzumab) as a single agent
• Lapatinib (Tyverb)
• Neratinib (Nerlynx)
• Olaparib (Lynparza)
• Palbociclib (Ibrance) + aromatase inhibitor*
• Palbociclib (Ibrance) + Fulvestrant (Faslodex)
• Pertuzumab (Perjeta) + trastuzumab + docetaxel
• Ribociclib (Kisqali) + aromatase inhibitor*
• Ribociclib (Kisqali) + Fulvestrant (Faslodex)
• Talazoparib (Talzenna)
• Trastuzumab emtansine (Kadcyla)
• Other active systemic anti-cancer therapy **
*aromatase inhibitor eg. Anastrozole, Exemestane or Letrozole
**eg. docetaxel, vinorelbine or capecitabine as a single agent
Q2. For the above patients, how many of these received their first ever dose for each product line?
Thank you for answering these questions.
Yours faithfully,
Phil Early
Dear P Early
Please find attached acknowledgement of your FOI request
Regards
FOI Manager
Shropshire Community Health Trust
Ptarmigan House, shrewsbury Business Park, Shrewsbury, SY2 6LG
[1]Good
Dear P Early
Please find attached response to your FOI request
Regards
FOI Manager
Shropshire Community Health Trust
Ptarmigan House, shrewsbury Business Park, Shrewsbury, SY2 6LG
[1]Good
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now